Biomarkers for the Progression of Intermediate Age-Related Macular Degeneration

Biomarkers for the Progression of Intermediate Age-Related Macular Degeneration

Abstract Age-related macular degeneration (AMD) is a leading cause of severe vision loss worldwide, with a global prevalence that is predicted to substantially increase. Identifying early biomarkers indicative of progression risk will improve our ability to assess which patients are at greatest risk...

Detaylı Bibliyografya
Asıl Yazarlar:	Eleonora M. Lad, Robert P. Finger, Robyn Guymer
Materyal Türü:	Makale
Dil:	English
Baskı/Yayın Bilgisi:	Adis, Springer Healthcare 2023-09-01
Seri Bilgileri:	Ophthalmology and Therapy
Konular:	Age-related macular degeneration Biomarkers iAMD Geographic atrophy Neovascular AMD
Online Erişim:	https://doi.org/10.1007/s40123-023-00807-9

Benzer Materyaller

Patterns of Gene Expression, Splicing, and Allele-Specific Expression Vary among Macular Tissues and Clinical Stages of Age-Related Macular Degeneration
Yazar:: Treefa Shwani, ve diğerleri
Baskı/Yayın Bilgisi: (2023-11-01)

Age-Related Macular Degeneration: Classification and Pathogenesis
Yazar:: İmren Akkoyun
Baskı/Yayın Bilgisi: (2014-12-01)

Current and Novel Therapeutic Approaches for Treatment of Neovascular Age-Related Macular Degeneration
Yazar:: Reem H. ElSheikh, ve diğerleri
Baskı/Yayın Bilgisi: (2022-11-01)

Serum lipids in adults with late age-related macular degeneration: a case-control study
Yazar:: Richard D. Semba, ve diğerleri
Baskı/Yayın Bilgisi: (2019-01-01)

Off-Label Use of Bevacizumab in Patients Diagnosed with Age-Related Macular Degeneration: A Systematic Review and Meta-Analysis
Yazar:: João Estarreja, ve diğerleri
Baskı/Yayın Bilgisi: (2024-07-01)

Genetics and Age-Related Macular Degeneration: A Practical Review for Clinicians
Yazar:: Julia Nguyen, ve diğerleri
Baskı/Yayın Bilgisi: (2024-02-01)

Potential Therapeutic Candidates for Age-Related Macular Degeneration (AMD)
Yazar:: Sonali Nashine
Baskı/Yayın Bilgisi: (2021-09-01)

Age-Related Macular Degeneration: Therapeutic Strategies and Future Approaches
Yazar:: Răzvan Vasile ROPCIUC
Baskı/Yayın Bilgisi: (2024-05-01)

A comprehensive review on early detection of drusen patterns in age-related macular degeneration using deep learning models
Yazar:: Kiruthika M, ve diğerleri
Baskı/Yayın Bilgisi: (2025-02-01)

Global Insights from Patients, Providers, and Staff on Challenges and Solutions in Managing Neovascular Age-Related Macular Degeneration
Yazar:: Anat Loewenstein, ve diğerleri
Baskı/Yayın Bilgisi: (2024-12-01)

Role of Complement in the Onset of Age-Related Macular Degeneration
Yazar:: Niloofar Piri, ve diğerleri
Baskı/Yayın Bilgisi: (2023-05-01)

The Role of Inflammation in Age-Related Macular Degeneration—Therapeutic Landscapes in Geographic Atrophy
Yazar:: Grace A. Borchert, ve diğerleri
Baskı/Yayın Bilgisi: (2023-08-01)

Etiopathogenesis of non-exudative age-related macular degeneration (literature review)
Yazar:: M. M. Bikbov, ve diğerleri
Baskı/Yayın Bilgisi: (2022-03-01)

Plasma Metabolites Associated with OCT Features of Age-Related Macular Degeneration
Yazar:: Ines Lains, MD, PhD, ve diğerleri
Baskı/Yayın Bilgisi: (2024-01-01)

Cost-effectiveness analysis of brolucizumab versus aflibercept for the treatment of neovascular age-related macular degeneration (nAMD) in Italy
Yazar:: Nicola Ferrante, ve diğerleri
Baskı/Yayın Bilgisi: (2022-04-01)

Early and intermediate age-related macular degeneration: update and clinical review
Yazar:: García-Layana A, ve diğerleri
Baskı/Yayın Bilgisi: (2017-10-01)

Prevalence of insomnia and depression in patients with age-related macular degeneration
Yazar:: Elżbieta Nowak, ve diğerleri
Baskı/Yayın Bilgisi: (2018-07-01)

Plasma Metabolomics of Intermediate and Neovascular Age-Related Macular Degeneration Patients
Yazar:: Sabrina L. Mitchell, ve diğerleri
Baskı/Yayın Bilgisi: (2021-11-01)

Intravitreal Brolucizumab in Patients with Aflibercept-Resistant Neovascular Age-Related Macular Degeneration
Yazar:: Ashwin Gupta, ve diğerleri
Baskı/Yayın Bilgisi: (2022-01-01)

Eye Drop with Fas-Blocking Peptide Attenuates Age-Related Macular Degeneration
Yazar:: Yujong Yi, ve diğerleri
Baskı/Yayın Bilgisi: (2024-03-01)

Dry and neovascular “wet” age-related macular degeneration: Upcoming therapies
Yazar:: Audrey Yan, ve diğerleri
Baskı/Yayın Bilgisi: (2025-01-01)

Linking Adiponectin and Its Receptors to Age-Related Macular Degeneration (AMD)
Yazar:: Mayank Choubey, ve diğerleri
Baskı/Yayın Bilgisi: (2023-11-01)

Efficacy and safety of brolucizumab versus aflibercept in patients with neovascular age-related macular degeneration: a randomized trial in Indian patients
Yazar:: Sanjay Kumar Mishra, ve diğerleri
Baskı/Yayın Bilgisi: (2022-07-01)

Antioxidants in Age-Related Macular Degeneration: Lights and Shadows
Yazar:: Uday Pratap Singh Parmar, ve diğerleri
Baskı/Yayın Bilgisi: (2025-01-01)

Genetic Insights into Age-Related Macular Degeneration
Yazar:: Bhumika, ve diğerleri
Baskı/Yayın Bilgisi: (2024-07-01)

Safety and efficacy of Razumab™ (world’s first biosimilar ranibizumab) in wet age-related macular degeneration: a post-marketing, prospective ASSET study
Yazar:: Shashikant Sharma, ve diğerleri
Baskı/Yayın Bilgisi: (2021-03-01)

Retinal Progression Biomarkers of Early and Intermediate Age-Related Macular Degeneration
Yazar:: Rita Flores, ve diğerleri
Baskı/Yayın Bilgisi: (2021-12-01)

Berries and Their Active Compounds in Prevention of Age-Related Macular Degeneration
Yazar:: Xiang Li, ve diğerleri
Baskı/Yayın Bilgisi: (2024-12-01)

Oxidative Stress, Persistent Inflammation and Blood Coagulation Alterations in Serum Proteome of Patients with Neovascular Age-Related Macular Degeneration
Yazar:: Mateusz Winiarczyk, ve diğerleri
Baskı/Yayın Bilgisi: (2024-05-01)

Dietary and Lifestyle Factors Modulate the Activity of the Endogenous Antioxidant System in Patients with Age-Related Macular Degeneration: Correlations with Disease Severity
Yazar:: Zofia Ulańczyk, ve diğerleri
Baskı/Yayın Bilgisi: (2020-10-01)

Novel Epigenetic Clock Biomarkers of Age-Related Macular Degeneration
Yazar:: Saurav Mallik, ve diğerleri
Baskı/Yayın Bilgisi: (2022-06-01)

Efficacy and Safety of Nutraceutical Support in Age-Related Macular Degeneration Patients
Yazar:: S. V. Yanchenko, ve diğerleri
Baskı/Yayın Bilgisi: (2023-01-01)

Deep Learning Approach for Age-related Macular Degeneration Detection Using Retinal Images: Efficacy Evaluation of Different Deep Learning Models
Yazar:: Ngoc Thien Le, ve diğerleri
Baskı/Yayın Bilgisi: (2023-12-01)

A prospective, randomized, parallel group, double blind, multicenter study to compare the efficacy, safety and immunogenicity of Lupin's Ranibizumab with Lucentis® in patients with neovascular age-related macular degeneration
Yazar:: Ramandeep Singh, ve diğerleri
Baskı/Yayın Bilgisi: (2022-01-01)

Treatment Strategies for Anti-VEGF Resistance in Neovascular Age-Related Macular Degeneration by Targeting Arteriolar Choroidal Neovascularization
Yazar:: Yingbin Fu, ve diğerleri
Baskı/Yayın Bilgisi: (2024-02-01)

Case Series on Initial Responses to Intravitreal Brolucizumab in Patients with Recalcitrant Chronic Wet Age-Related Macular Degeneration
Yazar:: Avaylon J, ve diğerleri
Baskı/Yayın Bilgisi: (2020-05-01)

Geographic Atrophy after Reabsorption of Pigment Epithelial Detachment (GARPED) study
Yazar:: Enoch T. Peng, ve diğerleri
Baskı/Yayın Bilgisi: (2023-05-01)

Exploring the role of granzyme B in subretinal fibrosis of age-related macular degeneration
Yazar:: Karanvir Gill, ve diğerleri
Baskı/Yayın Bilgisi: (2024-07-01)

Anatomical and functional responses to single brolucizumab injection in neovascular age-related macular degeneration patients not responding to antiangiogenics: a case series
Yazar:: Silvio Zuccarini, ve diğerleri
Baskı/Yayın Bilgisi: (2022-03-01)

Genetic Association between MMP9 and Choroidal Neovascularization in Age-Related Macular Degeneration
Yazar:: Elliott H. Sohn, MD, ve diğerleri
Baskı/Yayın Bilgisi: (2021-03-01)